What is positron emission tomography? Positron emission tomography (PET) is a non-invasive nuclear imaging technique which uses radioactive tracers. PET scans specifically look at the metabolism of a ...

Positron emission tomography (PET) is a type of imaging scan that doctors might use when diagnosing and treating non-Hodgkin’s lymphoma (NHL). It can be useful for identifying and staging the cancer.

PET scans require dietary preparation, sometimes up to 24 hours before the test, so it's important to know which foods to eat ...

Diagnostic imaging plays an important role in the care of patients with breast cancer and is used for breast cancer detection, diagnosis, staging, and therapeutic response evaluation. 1 Advances in ...

Both Hodgkin's disease (HD) and aggressive non-Hodgkin's lymphoma (NHL) are curable malignancies. With standard induction therapies (Armitage et al, 1986; DeVita et al, 1997; Gianni et al, 1997) more ...

A new study in the New England Journal of Medicine has established that, at least in the case of lymphoma, a positron emission tomography (PET) scan can spare the patients serious side effects of ...

Positron emission tomography (PET) scans can detect cancer earlier than other imaging tests. But some types of cancer are harder to detect on a PET scan. In particular, they may miss cancers that ...

We tested interim positron-emission tomography–computed tomography (PET-CT) as a measure of early response to chemotherapy in order to guide treatment for patients with advanced Hodgkin’s lymphoma.

Simultaneous scans: Positronium lifetime image (left) and standardized uptake value image (right) of a phantom containing tumour and adipose tissue samples, recorded using the Jagiellonian-PET scanner ...

Controversial aspects of the regulatory framework for compounding drug products used in positron emission tomography (PET) are discussed. The Food and Drug Administration Modernization Act of 1997 ...